Literature DB >> 11939555

High-performance affinity chromatography: a powerful tool for studying serum protein binding.

David S Hage1.   

Abstract

High-performance affinity chromatography (HPAC) is a method in which a biologically-related ligand is used as a stationary phase in an HPLC system. This approach is a powerful means for selectively isolating or quantitating agents in complex samples, but it can also be employed to study the interactions of biological systems. In recent years there have been numerous reports in which HPAC has been used to examine the interactions of drugs, hormones and other substances with serum proteins. This review discusses how HPAC has been used in such work. Particular attention is given to the techniques of zonal elution and frontal analysis. Various applications are provided for these techniques, along with a list of factors that need to be considered in their optimization and use. New approaches based on band-broadening studies and rapid immunoextraction are also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939555     DOI: 10.1016/s0378-4347(01)00482-0

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  61 in total

1.  Analysis of Drug Interactions with Lipoproteins by High-Performance Affinity Chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Adv Med Biol       Date:  2012

2.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.

Authors:  K S Joseph; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2010-05-06       Impact factor: 3.935

3.  Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.

Authors:  K S Joseph; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-06-01       Impact factor: 3.205

4.  Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs.

Authors:  Jianzhong Chen; David S Hage
Journal:  Anal Chem       Date:  2006-04-15       Impact factor: 6.986

5.  Analysis of free drug fractions using near-infrared fluorescent labels and an ultrafast immunoextraction/displacement assay.

Authors:  Corey M Ohnmacht; John E Schiel; David S Hage
Journal:  Anal Chem       Date:  2006-11-01       Impact factor: 6.986

Review 6.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

7.  Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Donald Jobe; Jared Beyersdorf; David S Hage
Journal:  J Chromatogr A       Date:  2015-09-09       Impact factor: 4.759

8.  Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Jeanethe Anguizola; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2012-10-08       Impact factor: 4.759

9.  Development of an affinity silica monolith containing human serum albumin for chiral separations.

Authors:  Rangan Mallik; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2007-03-24       Impact factor: 3.935

10.  Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography.

Authors:  Mandi L Conrad; Annette C Moser; David S Hage
Journal:  J Sep Sci       Date:  2009-04       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.